- Home
- CDIO vs ADXN Comparison
CDIO vs ADXN Comparison
Compare CDIO & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- ADXN
- Stock Information
- Founded
- CDIO 2017
- ADXN 2002
- Country
- CDIO United States
- ADXN Switzerland
- Employees
- CDIO N/A
- ADXN N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- CDIO Health Care
- ADXN Health Care
- Exchange
- CDIO Nasdaq
- ADXN Nasdaq
- Market Cap
- CDIO 12.4M
- ADXN 11.3M
- IPO Year
- CDIO N/A
- ADXN N/A
- Fundamental
- Price
- CDIO $0.27
- ADXN $8.25
- Analyst Decision
- CDIO Buy
- ADXN Strong Buy
- Analyst Count
- CDIO 1
- ADXN 1
- Target Price
- CDIO $2.00
- ADXN $30.00
- AVG Volume (30 Days)
- CDIO 5.4M
- ADXN 56.3K
- Earning Date
- CDIO 11-13-2024
- ADXN 11-22-2024
- Dividend Yield
- CDIO N/A
- ADXN N/A
- EPS Growth
- CDIO N/A
- ADXN N/A
- EPS
- CDIO N/A
- ADXN 0.05
- Revenue
- CDIO $39,138.00
- ADXN $960,641.00
- Revenue This Year
- CDIO $2,093.61
- ADXN N/A
- Revenue Next Year
- CDIO $43.05
- ADXN N/A
- P/E Ratio
- CDIO N/A
- ADXN $1.44
- Revenue Growth
- CDIO 1363.10
- ADXN N/A
- 52 Week Low
- CDIO $0.19
- ADXN $5.00
- 52 Week High
- CDIO $3.56
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- CDIO 51.62
- ADXN 35.21
- Support Level
- CDIO $0.21
- ADXN $8.36
- Resistance Level
- CDIO $0.52
- ADXN $11.68
- Average True Range (ATR)
- CDIO 0.07
- ADXN 1.00
- MACD
- CDIO 0.01
- ADXN -0.24
- Stochastic Oscillator
- CDIO 31.55
- ADXN 8.43
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.